Home > News > Computed Tomography Perfusion Maps and Final Infarction with Hyper-acute Stroke Patients Who Achieved Catheter Thrombolysis Therapy
Stroke
Read Time: 6 mins

Computed Tomography Perfusion Maps and Final Infarction with Hyper-acute Stroke Patients Who Achieved Catheter Thrombolysis Therapy

Published Online: June 4th 2011 European Neurological Review, 2008;3(2):61-63 DOI: http://doi.org/10.17925/ENR.2008.03.02.61
Authors: Yukari Naito
Quick Links:
Article
Article Information
Article:

The Cerebral Stroke Center at Wakakusa Daiichi Hospital in Japan used computed tomography perfusion (CTP) for selecting candidates for catheter thrombolysis therapy from June 2002 to June 2005, until the treatment guidelines, which were for thrombolysis therapy by intravenous administration of recombinant tissue-type plasminogen activator (alteplase) for hyper-acute cerebral stroke patients, were established by the Japan Stroke Society.1,2 No previous study in Japan had investigated the correlation between the pre-treatment CTP maps and the outcome after intra-arterial catheter thrombolysis therapy with hyper-acute stroke patients.
Lev et al. described a correlation between cerebral perfusion volume reduction area and a final infarction lesion after catheter thrombolysis therapy in a perfusion-weighted CT study of hyper-acute cerebral stroke cases.3 However, they did not include an investigation of mean transit time (MTT) in the study.
Eastwood et al. reported that prolonged MTT areas are larger than cerebral blood flow (CBF) and cerebral blood volume (CBV) reduction areas.4,5 The collateral vessels have been reported to influence MTT.4 Prolonged MTT areas with the box-modified transfer function (box- MTF) method (deconvolution analysis CTP software) are known to include a tracer delay developed to circulate a roundabout route of collateral vessels.6,7
In the current study, relationships between the location and site of the prolonged MTT areas as pre-treatment states and final infarction areas after intra-arterial catheter thrombolysis therapy with hyper-acute stroke patients were investigated using box-MTF analysis software. We also included evaluations of CBF and CBV reduction areas, collateral vessel development based on findings of CT angiography (CTA), outcome of thrombolysis therapy, presence of hemorrhage as a complication after therapy, and patient outcome after catheter thrombolysis.

Materials and Methods

Plain CT, CTP, and CTA were performed on 22 hyper-acute stroke patients who were brought to the emergency room of Wakakusa Daiichi Hospital within six hours of onset. All 22 patients with ischemic lesions were treated immediately with catheter thrombolysis after the CTP study. The occlusion vessels and collateral vessels were confirmed by CTA. Each CTP and CTA condition is shown in Table 1. Follow-up CT was performed to examine the presence of the final infarction after thrombolysis (see Figure 1). Image acquisition was performed according to the methods and scanning technique described by Yukari et al.8

Patients

As a result of severe motion artifact or defects of maps, seven cases were defaulted and 15 of the 22 patients were selected for inclusion in the study (see Table 2). There were 10 males and five females, with ages ranging from 38 to 82 years (average 63.5 years). There were two intracranial artery (ICA) occlusion cases, nine middle cerebral artery (MCA) occlusion site cases, and five basilar artery (BA) occlusion cases. Patients were investigated by CTP study over 35–320 minutes after stroke onset. We evaluated the patients’ outcome regarding activities of daily living (ADL) and the modified Rankin scale (MRS) at the time of discharge from hospital after receiving intra-arterial catheter thrombolysis therapy (see Table 3).

Catheter Angiography and Thrombolysis

Post-treatment arteriographic images were retrospectively analyzed regarding the achievement rate of recanalization as follows: successful—occluded vessels were recanalized and the peripheral vessels were delineated as expected; partly successful—occluded vessels were recanalized but irregular thicknesses of vascular walls were shown and the peripheral vessels were less delineated than normal; and failed—recanalization was not achieved (see Figure 2).

Imaging Analysis

The location and approximate size of prolonged MTT, decreased CBF and CBV in CTP study, and the final infarction areas on CT study were investigated with cerebral arterial territory.

Results

Abnormal perfusion areas detected by the box-MTF study were shown with CTP maps of CBF, CBV, and MTT in all of the 15 hyper-acute stroke patients (see Table 2).
Catheter thrombolysis therapy was successful in 12 of 15 patients. However, hemorrhage occurred in six of the 12 patients after thrombolysis. Excluding one case, hemorrhage occurred in the CBV reduction areas. Only in 11 cases did hemorrhage occur by the interventional technique. Final infarction was seen in all of the 15 patients. The decreased CBF areas showed nearly equal sites to the prolonged MTT areas in 15 patients. In all of the 15 patients the decreased CBV areas were identified in the prolonged MTT area and were smaller than the final infarct areas, although all of them resulted in either infarct or hemorrhage. The increased CBV areas were found in prolonged MTT areas only with BA-occluded hyper-acute stroke patients.
Among 12 patients with successful catheter thrombolysis, the final infarction areas were smaller than the prolonged MTT areas with two patients, including ICA occlusion (case one) and MCA occlusion (case four).
The final infarction area in case four with partial recanalization during the catheter thrombolysis therapy was almost equal to the prolonged MTT area. Another ICA occlusion patient had broad hemorrhage after recanalization. The remaining three patients of 15 could not obtain recanalization. The infarct was found in the corresponding site of prolonged MTT areas with MCA occlusion patients. However, in ICA occlusion patients without recanalization, the final infarction area was identified at the decreased CBV area, which was smaller than the prolonged MTT area. Regarding the comprehensive outcome of patients with recanalization of MCA and BA occlusion, ADL at the time of discharge from hospital was favorable, showing MRS of 0 to II, except for two patients (case six and case 15), who had hemorrhage at the basal ganglia or pons. Patients without recanalization of MCA occlusion, and ICA occlusion patients, had a poor outcome, showing MRS of IV or V.

Discussion

CTP can be performed soon after plain CT for emergent cases, which can show abnormal perfusion sites in a short time.4,7,9–13 In our investigation with the box-MTF method, we found that the locations and areas of CBF reduction sites were nearly identical to the prolonged MTT areas (see Table 2).
Although magnetic resonance perfusion and CTP studies do not have the same results with hyper-acute stroke patients, several papers have reported that prolonged MTT areas in perfusion studies were larger in size than the final infarct areas, and sometimes than CBF reduction areas, with or without thrombolysis therapy.14–21 In addition, in some reports, MTT indicated by the box-MTF method included tracer delay and overestimated true prolonged MTT areas, and thus CBF was underestimated.4–7,11,22–24 However, as was reported in a previous article,8 in cases with MCA occlusion without recanalization by catheter thrombolysis, the prolonged MTT areas were almost equal to the final infarction sites.
CTA examination of the patients with failure of MCA recanalization showed the infusion of contrast media from the posterior cerebral artery to the MCA occlusion area by way of collateral vessels. The box-MTF method applied in the study has shown no differentiation between the tracer delay areas and true prolonged MTT areas. We consider that if recanalization with MCA occlusion is not achieved in the prolonged MTT areas of the box-MTF method, vascular flow through collateral vessels may be disturbed in the timecourse, leading to the mechanism of CBV reduction beyond the compensatory range that Powers et al. and others stated, and resulting in final infarction.25–27
Almost the same mechanism and collateral vessel development might be suggested in BA or ICA occlusion cases but with different circulation factors.
The patients who had CBV reduction areas in the prolonged MTT areas had either hemorrhage or infarct, irrespective of recanalization after thrombolysis therapy. This agreed with the published papers. However, it was difficult to estimate whether CBV reduction areas of the prolonged MTT areas led to hemorrhage or infarct after thrombolysis therapy.
In case four, for whom catheter thrombolysis therapy partly succeeded, the prolonged MTT area and final infarction area coincided. Case four had no complications of cardiac disease and received traumatic dissection of the CA at the time of catheter thrombolysis therapy. A possibility of a creeping thrombus into the partly recanalized MCA or the formation of embolus was considered in this case.
In some cases of BA occlusion, increased CBV areas were identified in prolonged MTT areas. Final infarction areas were found only in the decreased CBV areas in the prolonged MTT sites. Although there was no report about CBV change in the prolonged MTT areas with BA-occluded hyper-acute stroke patients, these facts might correlate with the positive prognosis of BA-occluded patients. However, in case 15, who achieved recanalization by the catheter thrombolysis, pontine hemorrhage occurred and the patient died.
When a decreased CBV area in the prolonged MTT areas is noticed before thrombolysis, mortal pontine hemorrhage after recanalization should be considered carefully. In the patients, the outcome of MCA occlusion and BA occlusion, both in ADL and MRS at the time of discharge from hospital, was relatively favorable in cases of successful thrombolysis except for two cases, even though partial hemorrhage occurred, as the sites of hemorrhage and final infarct were small.
As reported by Ueda et al.,28 ICA occlusion cases had poor prognosis even with recanalization. However, in cases of MCA or BA occlusion, when prolonged MTT areas are large in size on CTP study, and with small decreased CBV area and sometimes with large increased CBV area, regarding collateral vessel development on CTA study, although careful consideration is necessary, catheter thrombolysis therapy is recommended.29–33
In summary, the current CTP study with the box-MTF method for hyper-acute stroke patients suggests that when recanalization of CBV reduction areas in the prolonged MTT areas is achieved by catheter thrombolysis therapy, hemorrhage or infarct can occur, although limited to a localized CBV reduction area in size.
Therefore, if the site of the decreased CBV area is in the prolonged MTT area with BA occlusion on the brainstem, pontine hemorrhage after thrombolysis should be considered carefully. However, the outcome after catheter thrombolysis with full or partial recanalization with BA occlusion seems to end in a relatively positive outcome, with MRS from 0 to II after catheter thrombolysis.
In this study, in the case of unsuccessful thrombolysis therapy with MCA occlusion, final infarctions were identical to the prolonged MTT area. With the box-MTF method, the prolonged MTT areas included tracer delay and the true prolonged MTT areas, which could not be differentiated. It is considered necessary to investigate the possibility that an entire tracer delay area of MTT with MCA occlusion may result in final infarction when recanalization is not achieved. ■

Article Information:

References

  1. The Japan Stroke Society, Guidelines of rt-P intravenous injection treatment, Japan Journal of Stoke, 2005;27:330–51.
  2. Lee KH, Lee SJ, Cho S, et al., Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissuetype plasminogen activator in acute ischemic stroke, Arch Neurol, 2000;57:1000–1008.
  3. Lev MH, Segal AZ, Farkas J, et al., Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arteial thrombolysis. Prediction of final infarct volume and clinical outcome, Stroke, 2001;32:2021–8.
  4. Eastwood JD, Lev MH, Azhari T, et al., CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke, Radiology, 2002;222:227–36.
  5. Schramm P, Schellinger PD, Klotz E, et al., Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours’ duration, Stroke, 2004;35:1652–8.
  6. Axel L, Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique, Investigative Radiology, 1983;18:94–9.
  7. Kudo K, Reliability of CT and MR perfusion imaging: current problem and future view, Japan J of Diagnostic Imaging, 2005;25:1487–97.
  8. Yukari N, Shigeko T, Yuichi I, et al., Hyperacute stroke patients and catheter thrombolysis therapy:correlation between computed tomography perfusion maps and final infarction, Radiat Med, 2008;26:227–36.
  9. Bisdas S, Donnerstag F, Ahl B, et al., Comparison of perfusion computed tomography with diffusion-weighted magnetic resonance imaging in hyperacute ischemic stroke, Neuroradiology, 2004;28:747–55.
  10. Koenig M, Kraus M, Theek C, et al., Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT, Stroke, 2001;32:431–7.
  11. Kudo K, Terae T, Katoh C, et al., Quantitative cerebral blood flow measurement with dynamic perfusion CT using the Vascular-pixel elimination method: comparison with H215O positron emission tomography, AJNR Am J Neuroradiol, 2003;24:419–26.
  12. Latchw RE, Yonas CH, Hunter GJ, et al., Guidelines and recommendations for perfusion imaging in cerebral ischemia. A scientific statement for healthcare professionals by the writing group on perfusion imaging, from the council on cardiovascular radiology of the American Heart Association, Stroke, 2003;34:1084–1104.
  13. Sparacia G,Iaia A, Assadi B, Lagalla R., Perfusion CT in acute stroke:predictive value of perfusion parameters in assessing tissue viability versus infarction, Radiol Med, 2007;112:113–22.
  14. Latchaw RE, Cerebral perfusion imaging in acute stroke, J Vasc Interv Radiol, 2004;15:S29–46.
  15. Wintermark M, Fischbein NJ, Smith WS, et al., Accuracy of dynamic perfusion CT with deconvolution in detecting acute hemispheric stroke, AJNR Am J Neuroradiol, 2005;26:104–12.
  16. Teksam M, Cakir B, Coskun M, CT perfusion imaging in the early diagnosis of acute stroke, Diagn Interv Radiol, 2005;11:202–5.
  17. Na DG, Ryoo JW, Lee KH, et al., Multiphasic perfusion computed tomography in hyperacute ischemic stroke: comparison with diffusion and perfusion magnetic resonance imaging, J Comput Assist Tomogr, 2003;27:194–206.
  18. Sorensen AG, Copen WA, Ostergaad L, et al., Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time, Radiology, 1999;210:519–27.
  19. Simonsen CZ, Rohl L, Vestergaard-poulsen P, et al., Final infarct size after acute stroke: prediction with flow heterogeneity, Radiology, 2002;225:269–75.
  20. Schaefer PW, Hunter GJ, He J, et al., Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging, AJNR Am J Neuroradiol, 2002;23:1785–94.
  21. Calamante F, Gadian DG, Connelly A, Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition, Magn Reson Med, 2000;44:466–73.
  22. Mayer TE, Hamann GF, Baranczyk J, et al., Dynamic CT perfusion imaging of acute stroke, AJNR Am J Neuroradiol, 2000;21:1441–9.
  23. Nambu K, Takehara T, Terada T, A method of regional cerebral blood perfusion measurement using dynamic CT with an iodinated contrast medium, Acta Neurol Scand, 1996;166:28–31.
  24. Koenig M, Klotz E, Luka B, et al., Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke, Radiology, 1998;209:85–93.
  25. Powers WJ, Press GA, Grubb RL, et al., The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation, Ann Int Med, 1987;106:27–35.
  26. Powers WJ, Raichle ME, Positron emission tomography and its application to the study of cerebrovascular disease in man, Stroke, 1985;16:361–76.
  27. Powers WJ, Cerebral hemodynamics in ischemic cerebrovascular disease, Ann Neurol, 1991;29:231–40.
  28. Ueda T, Sakaki S, Kumon Y, Ohta S, Multivariable analysis of predictive factors related to outcome at 6 months after intraarterial thrombolysis for acute ischemic stroke, Stroke, 1999;30:2360–65.
  29. Higashida RT, Furlan AJ, Roberts H, et al., Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke, Stroke, 2003;34:e109–37.
  30. Lisboa RC, Jovanovic BD, Alberts MJ, Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke, Stroke, 2002;33:2866–71.
  31. Furlan A, Higashida R, Wechsler L, et al., Intra-arterial prourokinase for acute ischemic stroke, JAMA, 1999;282:2003–11.
  32. Higashida RT, Furlan AJ, for the Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology and the Society of Interventional Radiology, Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke, Stroke, 2003;34:109–37.
  33. Camargo EC, Koroshetz WJ, Neuroimaging of ischemia and infarction, Neuro Rentogenology, 2005;2:265–76.

Further Resources

Share this Article
Related Content In Stroke
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72